GlassScriptPhysician profile
Rahul K Thaly
NPI 1598811713
$3,846.39
in general payments reported to CMS, 2019-2025
35 companies · $664 in 2025
The $664 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $431 · 2020: $896 · 2021: $408 · 2022: $494 · 2023: $471 · 2024: $483 · 2025: $664.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,618.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,618.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $696.50 | 2019-2020 | |
| Urogen Pharma, INC. | $366.69 | 2020-2025 | Jelmyto |
| Boston Scientific Corporation | $308.04 | 2019-2024 | Lithovue |
| Astellas Pharma US INC | $287.49 | 2019-2023 | Myrbetriq |
| Abbvie INC. | $211.53 | 2019-2024 | Lupron Depot |
| Coloplast Corp | $208.90 | 2019-2024 | Porges Coloplast, Vortek Hydro |
| Teleflex LLC | $190.53 | 2021-2025 | Barrigel, Urolift |
| Tolmar, INC. | $181.55 | 2023-2025 | Jatenzo, Eligard |
| Procept Biorobotics Corporation | $172.14 | 2022-2025 | |
| Janssen Biotech, INC. | $102.57 | 2019-2024 | Erleada |
| Baxter Healthcare | $93.85 | 2023-2024 | Floseal |
| Calyxo, INC. | $84.96 | 2023-2025 | Cvac Aspiration System |
| Myovant Sciences INC. | $84.80 | 2021-2022 | |
| Progenics Pharmaceuticals, INC. | $79.31 | 2023-2025 | Pylarify |
| Sumitomo Pharma America, INC. | $77.38 | 2023 | Gemtesa |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $67.15 | 2019-2024 | Harmonic, Echelon Flex |
| Clarus Therapeutics INC. | $65.81 | 2021 | |
| Myriad Genetic Laboratories, INC. | $62.88 | 2021-2022 | |
| Pfizer INC. | $62.77 | 2019 | |
| Axonics, INC. | $47.72 | 2023-2024 | Axonics |
| Urovant Sciences INC | $44.73 | 2022 | |
| Ferring Pharmaceuticals INC. | $42.14 | 2024 | Adstiladrin |
| Laborie Medical Technologies Corp. | $41.11 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Novartis Pharmaceuticals Corporation | $40.19 | 2021-2025 | |
| Tolmar Pharmaceuticals, INC. | $37.99 | 2022 | |
| Blue Earth Diagnostics | $37.27 | 2019-2021 | |
| Histosonics, INC. | $26.07 | 2024 | |
| Abbott Laboratories | $23.20 | 2022 | |
| Verity Pharmaceuticals INC. | $15.68 | 2025 | Tlando |
| Abc Home Medical Supply, INC. | $15.43 | 2025 | |
| C. R. Bard, INC. & Subsidiaries | $14.45 | 2024 | Bard Urinary Drainage Bag |
| Travere Therapeutics, INC. | $14.36 | 2020 | |
| Antares Pharma, INC. | $14.07 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $13.63 | 2023 | Seglentis |
| Endo Pharmaceuticals INC. | $13.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rahul Thaly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.